Home » Stocks » ADIL

Adial Pharmaceuticals, Inc. (ADIL)

Stock Price: $1.99 USD 0.00 (0.00%)
Updated Jan 21, 2021 12:41 PM EST - Market open
Market Cap 28.64M
Revenue (ttm) n/a
Net Income (ttm) -9.48M
Shares Out 13.65M
EPS (ttm) -0.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $1.99
Previous Close $1.99
Change ($) 0.00
Change (%) 0.00%
Day's Open 2.00
Day's Range 1.98 - 2.04
Day's Volume 149,448
52-Week Range 1.05 - 3.03

News

Hide News
Accesswire - 1 week ago

CHARLOTTESVILLE, VA / ACCESSWIRE / January 11, 2021 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on the dev...

Accesswire - 1 week ago

CHARLOTTESVILLE, VA / ACCESSWIRE / January 11, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for ...

Accesswire - 1 month ago

ONWARD™ Trial Remains on Track to be Fully Enrolled During Q2 2021 CHARLOTTESVILLE, VA / ACCESSWIRE / December 17, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage bio...

About ADIL

Adial Pharmaceuticals, a clinical-stage biopharmaceutical company, focuses on the development of treatment for addictions. Its lead product is AD04, a selective serotonin-3 antagonist for the treatment of alcohol use disorder. The company was founded in 2010 and is based in Charlottesville, Virginia.

Industry
Biotechnology
IPO Date
Jul 30, 2018
CEO
William B. Stilley III, M.B.A., MBA
Employees
3
Stock Exchange
NASDAQ
Ticker Symbol
ADIL
Full Company Profile

Financial Performance

Financial Statements